Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A "non-invasive alternative" to liver biopsy?

Abstract

Authors

• Niki Katsiki
  First Department of Internal Medicine, Division of Endocrinology and Metabolism, Diabetes Center, Medical School, AHEPA University Hospital, Thessaloniki, Greece. Electronic address: nikikatsiki@hotmail.com.
• Amalia Gastaldelli
  Cardiometabolic Risk Laboratory, Institute of Clinical Physiology, Pisa, Italy.
• Dimitri P Mikhailidis
  Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, UK.

Keywords

External Resources